Latest News and Press Releases

Oslo, Norway, 19 May 2022 Vistin Pharma ASA (OSE: VISTIN), please find attached the minutes from the annual general meeting held on 19 May 2022. All matters were resolved as proposed in the call for...

Oslo, Norway, 28 April 2020 Vistin Pharma ASA (OSE: VISTIN), please find attached the call for the Annual General Meeting in Vistin Pharma, to be held on 19 May at 10:00 CEST. A physical...

Oslo, Norway, 27 April 2022 Please find attached the Annual Report for 2021 for Vistin Pharma ASA. There are no material changes in the financial statements compared to the preliminary full...

Oslo, Norway, 27th of April 2022 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the first quarter 2022 Revenue in first quarter ended at MNOK 33 compared...

Oslo, Norway, 20 April 2022 Vistin Pharma ASA will release its first quarter 2022 results on Wednesday 27th of April 2022. Vistin Pharma will host a conference call for all shareholders and...

Oslo, Norway, 17th of February 2022 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the fourth quarter 2021 Revenue in fourth quarter ended at MNOK 78...

CEO Kjell-Erik Nordby is currently on sick-leave, and the Board in Vistin Pharma, with effect from today, has appointed Magnus Tolleshaug as interim CEO. Magnus Tolleshaug has been employed in Vistin...

Oslo, Norway, 8 February 2022 Vistin Pharma ASA will release its fourth quarter 2021 results on Thursday 17th of February 2022. Vistin Pharma will host a conference call for all shareholders and...

Pactum AS, a closely related party to the primary insider and board member Espen W. Marcussen in Vistin Pharma ASA, has on 29 October 2021 sold 3,519,733 shares in Vistin Pharma ASA at NOK 19.50 per...

Oslo, Norway, 28th of October 2021 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the third quarter 2021 Revenue in third quarter ended at MNOK...